A detailed history of Nuveen Asset Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 248,629 shares of PRCT stock, worth $23.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
248,629
Previous 161,609 53.85%
Holding current value
$23.3 Million
Previous $9.87 Million 101.75%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $4.9 Million - $7.4 Million
87,020 Added 53.85%
248,629 $19.9 Million
Q2 2024

Aug 09, 2024

BUY
$45.73 - $69.19 $809,238 - $1.22 Million
17,696 Added 12.3%
161,609 $9.87 Million
Q1 2024

May 13, 2024

BUY
$40.38 - $50.75 $85,484 - $107,437
2,117 Added 1.49%
143,913 $7.11 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $1.01 Million - $1.77 Million
40,704 Added 40.26%
141,796 $5.94 Million
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $167,241 - $216,210
5,571 Added 5.83%
101,092 $3.32 Million
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $648,142 - $898,660
24,275 Added 34.07%
95,521 $3.38 Million
Q1 2023

May 15, 2023

SELL
$26.64 - $39.74 $5.6 Million - $8.35 Million
-210,130 Reduced 74.68%
71,246 $2.02 Million
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $1.18 Million - $1.43 Million
30,464 Added 12.14%
281,376 $11.7 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $2.33 Million - $3.83 Million
75,521 Added 43.06%
250,912 $10.4 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $4.66 Million - $7.09 Million
159,410 Added 997.5%
175,391 $5.73 Million
Q1 2022

May 16, 2022

BUY
$16.89 - $35.74 $84,602 - $179,021
5,009 Added 45.65%
15,981 $559,000
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $269,911 - $507,893
10,972 New
10,972 $274,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.